| Name | N-[2-(diethylamino)ethyl]-4-(methanesulfonamido)benzamide |
|---|---|
| Synonyms |
C14H23N3O3S
UNII-0NHB13IN3R Sematilide |
| Description | Sematilide (CK-1752) is a selective IKr channel blocker. Sematilide causes a concentration-dependent inhibition of the delayed rectifier K+ current (IC50=25 μM). Sematilide is a class III antiarrhythmic agent[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 25 μM (K+ current)[1] |
| In Vitro | Application of 10, 30, 100 and 300 μM Sematilide causes a concentration-dependent inhibition of the delayed rectifier K+ current (IC50=25 μM)[1]. |
| In Vivo | Sematilide (0.3-1.0 mg/kg, intravenously i.v.) is effective in a canine model of arrhythmia[2]. Animal Model: Mongrel dogs of either sex (10-18 kg body weight)[2] Dosage: 0.3, 1, 3, and 10 mg/kg Administration: I.v. infusions Result: Demonstrated antiarrhythmic effects at 0.3 and 3.0 mg/kg. |
| References |
| Density | 1.205 g/cm3 |
|---|---|
| Melting Point | 141-142 °C |
| Molecular Formula | C14H23N3O3S |
| Molecular Weight | 313.41600 |
| Exact Mass | 313.14600 |
| PSA | 86.89000 |
| LogP | 2.67440 |
| Index of Refraction | 1.558 |
| HS Code | 2935009090 |
|---|
|
~%
101526-83-4 |
| Literature: Lumma, William C.; Wohl, Ronald A.; Davey, David D.; Argentieri, Thomas M.; DeVita, Robert J.; et al. Journal of Medicinal Chemistry, 1987 , vol. 30, # 5 p. 755 - 758 |
| HS Code | 2935009090 |
|---|---|
| Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |